What does the Vectra report show?Vectra categorizes RA disease activity into low, moderate, or high disease activity. An initial Vectra score provides an objective, quantitative starting point to track RA disease activity over time with subsequent testing.
Vectra Score factors in age, gender and adiposity of the patient to provide personalized measurement of inflammation.
Risk of RP gives a patient's risk of rapid radiographic progression within one year.
Change in Score will show the difference between multiple scores and indicate if there has been a meaningful change, or no change in disease activity.
Vectra Score Interpretation provides a more detailed explanation of the Vectra Score, disease activity category, risk of radiographic progression and treatment plan consideration.
Vectra Scores Over Time is a rolling 3.5 year date range plus initial score consisting of 7 half-year periods.
As of 12/4/2017 Vectra Score has been adjusted based on age, gender and adiposity of the patient.
Meaningful Change: MID of 8 is the smallest absolute change in the Vectra Score this is likely to reflect change in disease activity.
Risk of RP Graph gives a patient's future risk of radiographic progression based on their Vectra Score.
The Vectra Score is calculated from the concentrations of the 12 biomarkers shown on this page, which represent different biological pathways involved in RA pathophysiology. The clinical application of individual biomarker values, which have different weighting in the Vectra algorithm, has not been established.
Includes the leptin range for all RA patients.
Result/Units: Concentrations of the individual biomarkers.
The RA range refers to the reference range for each biomarker based on a reference set of RA patients. This is the concentration range that contains the central 95% of results for that biomarker.
Patient biomarker level relative to levels in all patients in the RA reference set.
Includes a complete list of your patient's historical Vectra Scores.
Includes comments and details relevant to Vectra samples and patient care (e.g., reason behind sample rejection).